Skip to content

Clinical trials

Recruiting Breast Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Recruiting Country / region: Italy Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20121
20141
20161
20181
20194
20208
20217
202211
202329
202432
202545
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting156

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology15
Centro di Riferimento Oncologico - Aviano6
IRCCS Azienda Ospedaliero-Universitaria di Bologna6
AstraZeneca5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
Hoffmann-La Roche5
Istituti Clinici Scientifici Maugeri SpA5
Eli Lilly and Company4
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano4
Regina Elena Cancer Institute4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms156
Ovarian Neoplasms12
Neoplasm Metastasis10
Triple Negative Breast Neoplasms10
Colorectal Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Endometrial Neoplasms8
Lung Neoplasms8
Neoplasms8
Prostatic Neoplasms7

Trials

Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.